Researchers report that IL-1β serum levels can be elevated in inflammatory and non-inflammatory conditions as different as sepsis, cancer, chronic rheumatoid disease, allergic inflammation, and non-inflammatory tissue injury, and also that PBMC IL-1β secretory changes in various conditions lead to changes in their body fluid IL-1β concentrations [14,15,16,17]. This evidence concerns the gene IL1B and Sepsis.